To treat patients with a
catecholamine-secreting
glomus jugulare tumor, perioperative management is important. Perioperative
catecholamine hypersecretion causes severe problems in the treatment of a
catecholamine-secreting
glomus tumor. Therefore, a precise therapeutic strategy and perioperative management are required through collaboration of the endocrinology, anesthesiology, and endocrine surgery departments . We describe our perioperative management for
catecholamine-secreting
glomus jugulare tumor. The patient was a 31-year-old woman with a 50-mm
glomus jugulare tumor and a significantly elevated plasma
noradrenaline level of 21,165 pg/ml. Before the
surgery, oral α - blocker administration was initiated for ∼ 3 months, and her
body weight increased from 52 kg at the time of examination to 54.2 kg. Coil embolization of the
tumor vessel was performed 1 week before surgery, and the intense
tumor stain was reduced by 90%. The patient underwent almost total removal of the
tumor via
mastoidectomy with high cervical exposure via the transsigmoid approach. Postoperatively, plasma
noradrenaline decreased markedly. Preoperative pharmacologic stabilization and peri- and postoperative
anesthetic management are essential for the treatment of a
catecholamine-secreting
glomus jugulare tumor.